Xinhua Silk Road: Innovation, tradition deeply integrated on TCM trade fair in China’s Zhangshu City
BEIJING, Oct. 28, 2025 /PRNewswire/ -- China's Zhangshu City, a famed industrial hub of…
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas…
Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained Strong at 12.3%
Akums Drugs and Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization…
This Pharmacy Chain is Saving India INR 300 Cr a Year And You've Probably Never Heard of It
In India’s complex and expensive healthcare ecosystem, where sufferers still consume a…
EyePoint Announces Proposed Public Offering of Common Stock
October 14, 2025 16:35 ET | Source: EyePoint Pharmaceuticals, Inc. WATERTOWN, Mass.,…
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025 16:41 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
SI GROUP BUILDS EMEA DISTRIBUTION NETWORK THROUGH NEW PARTNERSHIP WITH AZELIS
New collaboration will expand SI Group's customer reach complementing its long-standing partnership…
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2025 17:20 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Oct.…
Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin
PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…